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he Study of the Liver. Published bSummary Primary gastrointestinal (GI) lymphoma accounts for 30e50% of all extranodal non-
Hodgkin’s lymphomas, making the GI tract the most common site of extranodal non-Hodgkin’s
lymphomas. Most GI lymphomas belong to the B cell lineage. Burkitt lymphoma (BL) is a highly
aggressive mature B cell neoplasm that occurs in three forms: endemic, sporadic, and
immunodeficiency-associated. Sporadic BL accounts for 1e2% of all adult lymphomas and usu-
ally presents as an abdominal manifestation of extranodal disease involving the distal ileum or
cecum. Primary BL of the duodenum is rare. However, this report emphasizes the importance
of awareness of the malignancy potential of duodenal polyps. We report the case of a 70-year-
old woman admitted to our ward with upper GI bleeding due to duodenal polyps. An upper GI
endoscopic examination showed button-like polyps with central depression, and an immuno-
histochemical study of the polyps revealed a high-grade B cell malignancy (BL). Consequently,
the patient was treated with aggressive chemotherapy. The tumors regressed after chemo-
therapy. Although primary duodenal Burkitt lymphoma is very rare, the possibility of malig-
nancy should be considered if a patient presents with duodenal button-like polyps with a
central depressed surface.
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Lymphomas are solid malignancies of the lymphoid system
and can be classified into Hodgkin’s and non-Hodgkin’s
lymphoma (NHL). Almost all lymphomas involving the
gastrointestinal (GI) tract are NHLs. Moreover, the GI tract
is the most common site of extranodal NHLs, accounting for
30e50% of all cases. Small intestinal NHLs can be sub-
divided into B cell and T cell lymphomas; however, the
latter are less common [1].
Burkitt lymphoma (BL) is a highly aggressive mature B cell
neoplasm that occurs in three forms: endemic, sporadic, and
immunodeficiency-associated. Sporadic BL accounts for
1e2% of all adult lymphomas and usually presents with
abdominal disease involving the sites of the distal ileum,
cecum, mesentery, or cecum and mesentery sites [2]. Pri-
mary BL of the small intestine involving the duodenum is
rare, and only a few cases have been documented in the
English literature. Here, we report the case of a 70-year-old
woman with rare sessile, button-like duodenal polyps, who
initially presented with upper GI bleeding but was finally
diagnosed with primary duodenal BL.Case report
A 70-year-old woman was admitted to our hospital because
of dyspnea on exertion and diffuse abdominal discomfort.Figure 1 (A) Multiple round, sessile, button-like polyp lesions wi
third portions of the duodenum (white arrows). (B) A button-like
duodenum. (C) Closer view of a round, button-like duodenal polypThe patient had noted one episode of melana prior to her
admission. Her physical examination results showed a sys-
tolic and diastolic pressure of 110/70 mmHg, a heart rate of
106 beats/min, clear breathing sounds, and no abdominal
rebounding pain, but slight tenderness over the epigastric
area. Her laboratory test results revealed the following:
hemoglobin level, 7.1 g/dL; mean cell volume, 66.7%; red
cell distribution width, 18.8%; reticulocyte volume, 0.5%;
creatinine level, 0.7 mg/dL; serum iron level, 13 mg/dL;
total iron-binding capacity, 409 mg/dL; ferritin level,
5.2 ng/mL; and a positive stool occult blood test. Because
of suspected iron deficiency anemia due to GI blood loss, an
upper GI endoscopy was performed to identify the bleeder.
Multiple round, sessile, button-like polyp lesions with a
slight central depression and ulceration over the top were
discovered, measuring approximately 1 cm in diameter, in
the second and third portions of the duodenum (Figs.
1Ae1C). The barium study of jejunum and ileum and co-
lonoscopy both showed negative finding. A contrast-
enhanced abdominal computed tomography scan showed
focal wall thickening of the duodenum (Fig. 2) and lymph-
adenopathy of the para-aortic area. A histopathological
examination of the duodenal biopsy specimens from the
polyp lesion showed sheets of neoplastic lymphoid infiltrate
in the mucosal layer (Fig. 3A). The immunohistochemical
staining showed that the cells were positive for leukocyte
common antigen, CD20 (Fig. 3B), CD10, and nuclear B cell
lymphoma (BCL-6), and were negative for CD3, CD56, CD5,th a slight central depression and ulceration in the second and
polyp (arrowheads) with bleeding in the second portion of the
lesion (arrowheads).
Figure 2 Focal wall thickening in the second portion of the
duodenum (white arrow).
Primary duodenal Burkitt lymphoma 35CD23, chromogranin, and B cell leukemia/lymphoma-2
(BCL-2). A very high Ki-67 index (>90%; Fig. 3C) was also
observed in the tumor cells. A bone marrow biopsy was
negative for tumor involvement. On the basis of these
findings, the patient was diagnosed with primary duodenalFigure 3 (A) Diffuse neoplastic lymphoid cells infiltrated in the m
100 original magnification). (B) Positive CD20 immunoreaction in
cell origin (CD20, 100 original magnification). (C) High Ki-67
magnification).BL, stage IIE, using the modified Ann Arbor staging system.
Consequently, this patient received systemic chemotherapy
with CHOP (cyclophosphamide, doxorubicin, vincristine,
and prednisolone) every 3 weeks for 10 courses. She ach-
ieved complete remission after aggressive treatment and
was still well 36 months after initial diagnosis.Discussion
BL, as first described by Dennis Burkitt in 1958, is a highly
aggressive NHL presenting frequently at extranodal sites or
as an acute leukemia. According to the World Health Or-
ganization Classification of Lymphoid Neoplasms, BL is
classified into mature B cell neoplasm and characterized by
the translocation and deregulation of the c-myc gene on
chromosome 8 [2]. Three distinct clinical forms of BL are
recognized: endemic, sporadic, and immunodeficiency-
associated. The sporadic type of BL accounts for 1e2% of
all adult lymphomas in Western Europe and the United
States.
Adult sporadic or immunodeficiency-associated BL with
extranodal disease usually involves the abdomen and affects
the bowel or intra-abdominal lymph nodes. Sometimes, the
liver, spleen, kidney, and ovary may be involved. Symptoms
may include abdominal pain, nausea, vomiting, bowel
obstruction, GI bleeding, acute appendicitis, biliary
obstruction, or intussusceptions [1e3]. In this study, our
patient initially presentedwith symptoms of anemia because
of tumor bleeding and diffuse abdominal discomfort.ucosa of the duodenal polyp (hematoxylin and eosin staining,
neoplastic lymphoid cells, suggesting that the tumor was of B
index in the neoplastic lymphoid cells (Ki-67, 40 original
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odenum is rare. The ileocecal region is reported to be the
most common site involved in the GI tract [5]. If the BL is
found in the GI tract other than the ileocecal region such as
duodenum or stomach, a survey of other parts of the small
bowel or colon should be performed. Gloria Silva et al [6]
reported the case of a 16-year-old male teenager who pre-
sented with BL and acute pancreatitis caused by an infiltra-
tive tumor of the gastric mucosa and duodenum with giant
ulcers. Liou et al [1] documented a gastric BL case with
endoscopic findings of bleeding from multiple donut-like
tumors in the body and the antrum of the stomach. Jeen
et al [7] reported an EpsteineBarr virus-related BL in the
terminal ileum with a diffusely infiltrative mass encircling
the ileal wall, which was stenotic with shallow ulcers,
mucosal nodularity, and blood clots. Endoscopic findings
such as those in our study have not been reported previously.
Here, we have reported the first case of BL with an endo-
scopic finding of round button-like polypoid lesions in the
duodenum.
BL cells express surface immunoglobulin M and B cell-
associated antigens (CD19, CD20, CD22, and CD79a) in
addition to CD10, HLA-DR, and CD43 [2]. The biopsied tissue
stained positive for CD10, CD20 (indicating B cell lineage),
and BCL-6 markers, which are also present on BL cells, and
stained negative for CD5, BCL-2, and CD23, which are
typically absent on BL cells [8]. A high proliferation fraction
and Ki-67 fraction of > 90% were noted. The results of the
standard immunohistochemical staining satisfied the diag-
nostic criteria for BL.
BL progresses rapidly and is fatal if not treated; how-
ever, it responds well to aggressive chemotherapy, and the
cure rates range from 50% to 90%, depending on the extent
of the disease [9]. Thus, early diagnosis is important for a
better clinical result. Surgery is seldom used in BL except
under emergent conditions including obstruction, perfora-
tion, and hemorrhage. Because the tumor responds
dramatically to chemotherapy, it can result in a rapid
regression of the tumors with full thickness involvement of
the bowel wall and subsequent perforation. According to
Vaidya et al’s [10] study, 5% of patients developed a
perforation after chemotherapy [10]. Bowel perforation in
GI lymphomas significantly contributes to the morbidity and
mortality, so early identification of patients with impendingperforation may permit early surgical intervention. In
conclusion, although primary duodenal BL is rare, the pos-
sibility of malignancy should be strongly suspected if a
patient presents with button-like polyps and central
depressed surface in the duodenum.Conflicts of interest
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